What the Wall Street Journal says
Survivorship and its problems are so important, impacting seriously on people’s lives, that the eminent business paper, The Wall Street Journal (WSJ) recently made space for a major article on the subject.
“When the treatment ends, the patients’ next journey is just beginning. They are left with new health issues often caused by the treatment itself, such as damage to the heart and other organs, or worsening high blood pressure and diabetes. Studies show many struggle with depression, fatigue and fear the cancer will return. Sexual function and personal relationships may suffer.
Compounding it all, survivors often feel alone and adrift as they face those challenges. According to a new survey of cancer survivors by the nonprofit National Coalition for Cancer Survivorship, few feel very prepared for the transition to post treatment, nor informed about how to manage their health going forward”.
So survivors face the same challenges both sides of the Atlantic.
What’s happening now
Once hospital treatment finishes, patients find they are no longer the centre of their team’s focus. The team is treating new cases, and the patient’s GP doesn’t have time nor expertise to deal with the complexities of survivor’s needs.
For cancer survivors in the States, the WSJ says rather than leaving patients to fend for themselves, providers are beginning to take a much more active role in helping patients deal with life after treatment.
They’re looking for new treatments that won’t take the punishing long-term physical toll that today’s regimens take. They’re focusing on how to help younger patients who will have the longest to live. And coming up with plans to figure out exactly what all patients need in the difficult years after treatment, helping providers and patients stick to the strategies.
The good news is ….
Nearly 40% of men and women will develop an invasive cancer in their lifetimes, with men at slightly higher risk. But thanks to medical advances in detection and treatment, numbers of cancer survivors are increasing.
In 2015, the Commission on Cancer, a programme of the American College of Surgeons, began requiring that, as a condition of accreditation, American hospitals provide patients with a survivorship-care plan. “We continue to learn more about the short- and long-term effects and complications of therapy, and patients’ problems today may be very different in a year or in five years,” their Dr. Shulman says.
What’s happening in UK
In the UK we have Long-term Plans, STPs, promises of Holistic Needs Assessments, etc. etc. But it all boils down to an enormous fight to get what survivors really need.
Outcomes aren’t improved by offering patients a one-time survivorship-care plan when they end treatment. Unlike in the States, where Insurance companies will demand that their clients are kept as healthy as possible, after cancer care in the UK can be very hit-and-miss. Extra funding allocated to cancer services can range from £1.30 per head, up to £5 – depending on where you live. Sadly there is a scandalous post-code lottery that has been allowed to develop, and if a patient complains the general attitude, from the CCG down, seems to ba a shrug of the shoulders.
Providing specialized care
With 200+ cancers, that means a variety of necessary treatments for patients—and then a variety of follow-up needs for survivors. The WSJ highlights it is crucial for survivors to be monitored by specialists who can assess their individual risk of recurrence and know the after-effects of specific chemotherapy and radiation regimes.
In the States there is a fast-growing model of care at hospitals around the country—matching survivors with caregivers trained to deal with their particular form of cancer. Without such surveillance, “long-term cancer survivors get lost to follow-up and may return years later with a new cancer that went unrecognized,” says Linda Jacobs, a clinical professor of nursing at Penn and founding director of the cancer-survivorship program.
In the UK the Dept.Health sets up plan after plan, yet seems scared of acting on any of its innumerable ‘long term plans’. GPs generally aren’t familiar with what is recommended for follow-up, nor do they necessarily recognize when someone presents with a symptom that would warrant further specific testing. As we see with constant horror media stories of cancer signs ignored.